ExpreS2ion will present its technology platform and pipeline at several key events in September and October 2020
ExpreS2ion Biotech Holding AB’s affiliate ExpreS2ion Biotechnologies ApS (“ExpreS2ion") will participate at several key events in September and October, including Aktiespararna’s Aktiedagen, September 15 in Lund, Sweden, World Vaccine Congress Washington Virtual, September 28–October 1, and World Vaccine Congress Europe Digital Event, October 19–21.During these and additional scientific and business partnering meetings, ExpreS[2]ion will present the advantages of the ExpreS[2] protein production and capsid virus-like particle (cVLP) technology platforms for vaccine discovery, preclinical